quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:00:23·27d
SECFiling
IDEXX Laboratories Inc. logo

SEC Form DEF 14A filed by IDEXX Laboratories Inc.

IDXX· IDEXX Laboratories Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • IDXX
    IDEXX Laboratories Inc.
    Health Care

Recent analyst ratings

  • Apr 15UpdateCitigroup$650.00
  • Dec 9UpdateBarclays$850.00
  • Oct 31UpdateStifel$700.00
  • Oct 1UpdateUBS$720.00
  • Aug 5UpdateBTIG Research$785.00
  • Jul 1UpdateJefferies$625.00

Related

  • ANALYST8d
    Citigroup initiated coverage on IDEXX Labs with a new price target
  • PR15d
    IDEXX Laboratories to Release 2026 First Quarter Financial Results
  • PR22d
    IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
  • SEC27d
    SEC Form DEFA14A filed by IDEXX Laboratories Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by IDEXX Laboratories Inc.
  • SEC28d
    IDEXX Laboratories Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • SEC41d
    SEC Form PRE 14A filed by IDEXX Laboratories Inc.
  • INSIDER49d
    EVP, GC & Corporate Secretary Underberg Sharon E. exercised 197 shares at a strike of $505.53, increasing direct ownership by 3% to 7,138 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022